- 2016
- Press releases - 20.10.2016
Gastroenteritis is back in metropolitan France
According to the Sentinelles network’s weekly bulletin of 19 October 2016, the incidence rate of acute diarrhoea reached epidemic levels in metropolitan France last week, with 155 cases observed in general medicine clinics per 100 000 inhabitants.
- What's on? - 20.10.2016
Gastroenteritis is back in metropolitan France
Sentinelles network’s bulletin of 19 October 2016 According to the Sentinelles network’s weekly bulletin of 19 October 2016, the incidence rate of acute diarrhoea reached epidemic levels in metropolitan France last week, with 155 cases observed in general medicine clinics per 100 000 inhabitants. The Sentinelles network adds that the current level of gastroenteritis is […]
- Press releases - 19.10.2016
Hepatitis C virus observed under a microscope for the first time
Scientists have finally observed the hepatitis C virus (or HCV) using an electron microscope. This is the first time since the virus became known in 1990. Inserm researchers at Tours (Inserm unit 966, “HIV and Hepatitis Viruses: Morphogenesis and Antigenicity”) have taken other scientists by surprise, including an American team believed to have accomplished this feat in 2013. The latter had in fact misunderstood the nature of the particles observed.
This research is published in the journal Gut.
- Press releases - 13.10.2016
Combating Ebola: Encouraging Results for the PREVAIL Clinical Trial
An international research team involving Inserm and the National Institutes of Health (NIH) has just published the results of the PREVAIL study on treatment for the Ebola virus. While not definitive, the results show that ZMapp may benefit patients with the Ebola virus disease.
These results are published in The New England Journal of Medicine.
- Press releases - 07.10.2016
Rituximab effective in the treatment of membranous glomerulonephritis
A national trial on membranous glomerulonephritis in 80 patients was coordinated by Prof. Pierre Ronco, of the Department of Nephrology and Dialysis at Tenon Hospital AP-HP, of the Inserm Unit “Rare and common kidney diseases, matrix remodelling and tissue repair” [1] and Pierre and Marie Curie University, and by Dr Karine Dahan, of the Nephrology Day Hospital at Tenon Hospital AP-HP. This serious autoimmune disease is the most common cause of nephrotic syndrome in adults. In 30% of cases, it progresses to very severe renal failure. Conducted in collaboration with Prof. Tabassome Simon, from the Department of Clinical Pharmacology and East Paris Clinical Research Centre at Saint Antoine Hospital, AP-HP, this trial shows, for the first time, the efficacy and safety of rituximab in treating the disease.
- Press releases - 06.10.2016
New immunotherapy-based approach for post-transplant leukaemia relapse
An Inserm team from the Mondor Institute for Biomedical Research (IMRB) has just identified a key switch in the immune response, and proposes a new immunotherapy-based approach for combating leukaemia. And maybe other cancers in time. This work is published in the journal Blood.
- News in brief - 05.10.2016
Exhibition « La Science a du gout »
Let’s discover how to eat well to live better! A fun-filled, tasty and interactive exhibition about the joy of eating, balanced diet and health. Meet our scientists, learn while you play, and let your senses guide you through the workshops! The Ministry of Higher Education and Research, INRA and Inserm invite you to this exhibition, […]
- Press releases - 05.10.2016
The gut microbiota to the rescue of chemotherapies
Two species of bacteria present in the gut boost the efficacy of cyclophosphamide-based chemotherapies by optimising the antitumour immunity induced by this drug. This is reported by researchers from Inserm, Gustave Roussy, CNRS, Institut Pasteur Lille, and the Universities of Paris Sud and of Lille in an article published on 4 October in the journal Immunity.
- Press releases - 05.10.2016
Eating well to grow well: discovery of a missing link
Rénald Delanoue, Inserm Researcher, and his colleagues at the Institute of Biology Valrose in Nice (Inserm-CNRS-Université Côte d’Azur) have identified the missing links in the process that regulates the size of an organism based on the richness of its diet. Their research was conducted on Drosophila, an insect that seems very distant from humans, but the study of which has nonetheless enabled many advances in biomedical research. This work is published in the 30 September 2016 issue of the journal Science.
- Press releases - 04.10.2016
1 in 2 French people suffers from joint pain
According to the results of an IFOP survey, “Les Français et les Rhumatismes” (Rheumatic Diseases and the French), conducted by Inserm and “Ensemble Contre les Rhumatismes” (Together Against Rheumatic Diseases), 93% of French people report having already suffered from joint pain[1] and one in two were suffering from it at the time of responding to the survey. This joint pain strongly affects their daily life. Quality of sleep and the ability to perform leisure activities are the two aspects of daily life that are most affected, ahead of working life and family life.